Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Curis and Debiopharm present data for Debio 0932 at Annual Meeting of AACR

Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).

8 Apr 2014

PatientsLikeMe collaborates with Genentech to develop innovative ways of researching patients' real-world experience with disease, treatment

PatientsLikeMe announced today a five-year agreement with Genentech, a member of the Roche Group, to explore use of PatientsLikeMe's global online patient network to develop innovative ways of researching patients' real-world experience with disease and treatment.

8 Apr 2014

Dream team aims to turn pancreatic cancer into treatable disease

UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.

8 Apr 2014

Arnold Palmer Hospital cardiologists perform Florida's first pediatric implant of new device to prevent sudden cardiac arrest

Cardiologists at Arnold Palmer Hospital for Children today performed Florida's first pediatric implant of a new device to prevent sudden cardiac arrest.

8 Apr 2014

Eli Lilly presents early-stage data from several targeted cancer therapies at AACR 2014

Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.

7 Apr 2014

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer

Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.

7 Apr 2014

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the Phase 2 cohort of the MD Anderson Cancer Center-sponsored Phase 1/2 study of quizartinib in combination with either 5-azacitidine or low dose cytarabine for previously untreated FLT3-ITD positive acute myeloid leukemia (AML) patients age 60 or older, or FLT3-ITD positive AML patients 18 years of age or older in first relapse.

7 Apr 2014

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.

7 Apr 2014

Deciphera Pharmaceuticals initiates Phase 1 clinical trial of pan-RAF inhibitor LY3009120

...

7 Apr 2014

Variations in woman's genome may contribute to her risk of developing ovarian cancer

Variations in a woman's genome may contribute to her risk of developing ovarian cancer. Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diego, CA.

7 Apr 2014

Helium ion radiotherapy provides hope for improved, accurate radiation treatment for young cancer patients

For the first time, researchers have been able to demonstrate that the use of helium ions in radiation therapy could provide accurate treatment to tumours while helping to spare healthy organs.

7 Apr 2014

Blood sample could diagnose many types of solid cancers

A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.

7 Apr 2014

Researchers examine role of antioxidants play in blocking harmful effects of omega 6 fatty acid

Given omega 6 fatty acid's reputation for promoting cancer - at least in animal studies - researchers are examining the role that antioxidants play in blocking the harmful effects of this culprit, found in many cooking oils.

7 Apr 2014

BMC joins SCCA Network, becomes tenth affiliate in the greater Northwest

Bend Memorial Clinic (BMC) has joined the Seattle Cancer Care Alliance (SCCA) Network to become its tenth affiliate in the greater Northwest. The affiliation will expand local access to cancer treatment options and help foster advances in cancer care.

4 Apr 2014

Transgenomic to provide genetic testing services for Raptor’s clinical trial

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing services for Raptor's clinical trial (RP103-MITO-001) evaluating RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.

4 Apr 2014

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

4 Apr 2014

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

Novartis announced today that early stage data on 19 investigational compounds in its oncology pipeline will be presented at the annual meeting of the American Association of Cancer Research, April 5-9, 2014 in San Diego, CA.

4 Apr 2014

Deutsche Forschungsgemeinschaft to establish 5 new Research Units

Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years

4 Apr 2014

Study shows high-risk drinking may improve post weight loss surgery

Much has been reported about the potential for increased risk of alcohol misuse after weight loss surgery (WLS), with most theories pointing to lower alcohol tolerance and a longer time to return to a sober state after surgery, but a new study from Beth Israel Deaconess Medical Center suggests that upwards of half of high-risk drinkers are actually less likely to report high-risk drinking behavior after weight loss surgery.

4 Apr 2014

Surgeons use Cyberknife robotic device for treatment of vocal cord cancer

Stephen Wiley, a lifelong cowboy from Terrell, has helped UT Southwestern Medical Center pioneer a new treatment for vocal cord cancer. Mr. Wiley volunteered to be the world's first known patient to be treated for vocal cord cancer with Cyberknife, a surgeon-controlled robotic device that destroys tumors with highly precise doses of radiation.

4 Apr 2014

Oncology News and Research

Further Reading

Curis and Debiopharm present data for Debio 0932 at Annual Meeting of AACR

PatientsLikeMe collaborates with Genentech to develop innovative ways of researching patients' real-world experience with disease, treatment

Dream team aims to turn pancreatic cancer into treatable disease

Arnold Palmer Hospital cardiologists perform Florida's first pediatric implant of new device to prevent sudden cardiac arrest

Eli Lilly presents early-stage data from several targeted cancer therapies at AACR 2014

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer

Ambit initiates Phase 2 study of quizartinib in acute myeloid leukemia patients

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

Deciphera Pharmaceuticals initiates Phase 1 clinical trial of pan-RAF inhibitor LY3009120

Variations in woman's genome may contribute to her risk of developing ovarian cancer

Helium ion radiotherapy provides hope for improved, accurate radiation treatment for young cancer patients

Blood sample could diagnose many types of solid cancers

Researchers examine role of antioxidants play in blocking harmful effects of omega 6 fatty acid

BMC joins SCCA Network, becomes tenth affiliate in the greater Northwest

Transgenomic to provide genetic testing services for Raptor’s clinical trial

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Novartis to present early stage data on 19 investigational compounds at AACR annual meeting

Deutsche Forschungsgemeinschaft to establish 5 new Research Units

Study shows high-risk drinking may improve post weight loss surgery

Surgeons use Cyberknife robotic device for treatment of vocal cord cancer

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News